L'Oreal/Nestle venture sweetens Q-med bid
STOCKHOLM (Reuters) - The L'Oreal (OREP.PA) and Nestle (NESN.VX) joint venture Galderma said on Thursday it was raising its bid for Swedish beauty treatments firm Q-Med QMED.ST by about 5 percent.
Galderma raised its bid to 79 crowns per share, valuing the company at $1.16 billion. Earlier this week, Galderma said its 75 crown per share bid had fallen well short of a target for 90 acceptances.
Galderma said owners holding just under 78 percent of shares had agreed to accept the raised offer.
BANGALORE/SYDNEY - Factory activity in Europe and Asia cooled in August after a strong July, as new orders dwindled in the face of escalating tensions in Ukraine and a patchy recovery in China, purchasing managers indexes showed.
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.